Chronic Lymphocytic Leukemia | Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in Chronic Lymphocytic Leukemia
FEB 27
Description Community
About

Featuring perspectives from Dr Lindsey Roeker and Dr Jeff Sharman, including the following topics:

  • An Audio Depiction of Mechanisms of Action of Bcl-2 Inhibitors, Anti-CD20 Antibodies and Covalent and Noncovalent Bruton Tyrosine Kinase Inhibitors; Mechanisms of Resistance (0:00)
  • Current Management Approaches for Patients with Chronic Lymphocytic Leukemia (CLL) — Dr Sharman (12:27)
  • Future Directions in the Care of Patients with CLL — Dr Roeker (33:54)

CME information and select publications

 

Comments